Quinn Opportunity Partners LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$214,000
-36.9%
52,876
-32.6%
0.01%
-65.9%
Q3 2019$339,000
+24.2%
78,438
+14.6%
0.04%
+20.6%
Q2 2019$273,000
-25.6%
68,4380.0%0.03%
-32.0%
Q1 2019$367,000
-17.5%
68,438
-21.1%
0.05%
-19.4%
Q4 2018$445,000
-32.0%
86,722
+28.6%
0.06%
-33.3%
Q3 2018$654,000
+11.6%
67,438
+17.4%
0.09%
+19.2%
Q2 2018$586,000
-21.6%
57,4380.0%0.08%
-18.8%
Q1 2018$747,00057,4380.10%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q3 2019.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders